Intrinsic Value of S&P & Nasdaq Contact Us

1933 Industries Inc. TGIFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
27/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

1933 Industries Inc. (TGIFF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 26/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $13M, +5.6%/yr average growth. Net income is $145,092 (loss), growing at +67.9%/yr. Net profit margin is -1.2% (negative). Gross margin is 41% (+19.5 pp trend).

Balance sheet: total debt is $18M with negative equity of -$5M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.6 (tight liquidity). Debt-to-assets is 145.2%. Total assets: $12M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 83/100 (Pass), Past 0/100 (Fail), Health 0/100 (Fail), Moat 43/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

TGIFF SharesGrow Score Overview

45/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 83/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 43/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0031-0.0172
Volume500
Avg Volume (30D)70.76K
Market Cap$3.22M
Beta (1Y)0.25
Share Statistics
Shares Outstanding$491.41M
IPO Date2013-05-22
Employees85
CEOBrian Farrell
Financial Highlights & Ratios
Revenue (TTM)$12.59M
Gross Profit$5.16M
EBITDA$631.87K
Net Income$-145.09K
Operating Income$-2.81M
Total Cash$545.98K
Total Debt$17.6M
Net Debt$17.06M
Total Assets$12.13M
Price / Sales (P/S)0.26
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA65442F1053

Price Chart

TGIFF
1933 Industries Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message